ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,547, issued on June 9, was assigned to University of Rochester (Rochester, N.Y.) and University of Copenhagen (Copenhagen, Denmark).
"Humanized chimeras for the prospective assessment of cell addition and replacement therapies" was invented by Steven A. Goldman (Webster, N.Y.) and Ricardo da Costa Barbedo Vieira (Denmark, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "A chimeric non-human mammal disease model, wherein (1) at least 30% of all the glial cells in the corpus callosum of the chimeric non-human mammal are human glial cells, and/or (2) at least 5% of all of the glial cells in the white matter of the brain and/or brain stem of the ch...